Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis
Open accessThe DOI matches its Crossref record; 312 of the 326 references it cites were found in a registry or an index; 153 of the 280 sources its claims cite were checked for support.
Abstract
Drug delivery to solid tumors is challenged by multiple physiological barriers arising from the tumor microenvironment, including dense extracellular matrix, cellular heterogeneity, hypoxic gradients, and elevated interstitial fluid pressure. These features hinder the uniform distribution and accumulation of therapeutics, reducing treatment efficacy. Despite their widespread use, conventional two-dimensional monolayer cultures fail to reproduce these complexities, contributing to the poor translational predictability of many preclinical candidates. Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms. Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk. Advances in spheroid analysis now enable detailed evaluation of drug penetration, cellular migration, cytotoxic response, and molecular gradients using techniques such as optical and confocal imaging, large-particle flow cytometry, biochemical viability assays, and microfluidic integration. By combining physiological relevance with analytical accessibility, spheroid models support mechanistic studies of drug transport and efficacy under tumor-like conditions. Their adoption into routine preclinical workflows has the potential to improve translational accuracy while reducing reliance on animal models.
Overview
CoChat Summary
TL;DR
This review argues that 3D multicellular tumor spheroids better capture tumor microenvironment barriers than 2D monolayers and can be analyzed with imaging, flow cytometry, viability assays, and microfluidics. It synthesizes TME biology, spheroid features, and analytical strategies to improve preclinical drug testing.
Key findings
- Spheroids reproduce spatial gradients seen in solid tumors: proliferative outer rim, quiescent intermediate zone, and hypoxic/necrotic core; these gradients typically emerge when spheroids exceed ~500 μm in diameter, core pH ranges between 6.5 and 7.2, and growth plateaus at approximately 600–800 µm.
- Stromal and ECM incorporation increases drug resistance: breast tumor spheroids with higher fibroblast content showed decreased dextran diffusion and diminished doxorubicin cytotoxicity, while pancreatic triple co-cultures of tumor cells, fibroblasts, and endothelial cells demonstrated greater drug resistance than spheroids lacking either stromal component.
- Spheroid gene expression more closely resembles solid tumors than monolayers: in melanoma spheroids, over 100 transcripts were upregulated and approximately 70 downregulated compared with monolayers; a meta-analysis of NCI-60 monolayers versus clinical tumor samples found about 30% of ~7000 genes with altered expression.
- Analytical approaches include brightfield/confocal/electron/SHG microscopy, large-particle flow cytometry, FLIM-BrdU, and microfluidic systems; large-particle flow cytometry tracked fibroblast migration toward the spheroid core by day 5 and endothelial cell clustering near fibroblasts.
Methods
- Narrative review; no systematic search strategy, inclusion criteria, or meta-analysis is described.
- Synthesizes published literature on TME components, limitations of 2D and in vivo models, spheroid biology, and techniques for spheroid analysis.
- No primary experimental data or sample; findings are drawn from cited studies and illustrative examples.
Limitations
- The paper does not state limitations.
- Evident from the review format: no systematic search or quantitative synthesis is reported, so literature coverage and conclusions may be non-exhaustive.
- Evident from the text: many cited findings come from specific cell lines and tumor models, and the review does not systematically assess reproducibility or generalizability across all tumor types.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
92 Valid · 7 Not valid · 43 Not checked · 20 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“cells located in the intermediate zone are often senescent”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > 5. Spheroids as a More Physiologically Relevant TME Model > 5.1. Internal Structure of Spheroids
What the sources say
- Not checked — no full text of the sourcecites [101] Benien P. Swami A. 3D tumor models: History, advances and future perspectives Future Oncol. 2014 10 1311 1327 10.2217/fon.13.274 24947267 source
- Disputedcites [184] Mehta G. Hsiao A.Y. Ingram M. Luker G.D. Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control Release 2012 164 192 204 10.1016/j.jconrel.2012.04.045 22613880 PMC3436947 sourceExperimental — accuracy not yet measured
In the Introduction section “Spheroids as appropriate models for drug delivery” (page not available), the paper describes the layer between the necrotic core and proliferating outer rim as quiescent, not senescent. Quiescence and senescence are distinct cellular states; the cited passage does not support substituting one for the other. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [186] Solomon M.A. Lemera J. D’Souza G.G. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics J. Liposome Res. 2016 26 246 260 10.3109/08982104.2015.1105820 26780923 source
- Could not verifycites [187] McIntyre A. Patiar S. Wigfield S. Li J.L. Ledaki I. Turley H. Leek R. Snell C. Gatter K. Sly W.S. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy Clin. Cancer Res. 2012 18 3100 3111 10.1158/1078-0432.CCR-11-1877 22498007 PMC3367109 sourceExperimental — accuracy not yet measured
The Results section describes hypoxia, proliferation, apoptosis and necrosis in spheroids, but does not identify an intermediate zone or characterize its cells as senescent. Searches for senescence, quiescence and the intermediate zone found no passage addressing the claim; page numbers were not available in our copy. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Together, these components create a tumor microenvironment (TME) that significantly influences drug penetration, retention, and therapeutic response [1,3,4].”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > 1. Introduction
What the sources say
- Supportedcites [1] Sriraman S.K. Aryasomayajula B. Torchilin V.P. Barriers to drug delivery in solid tumors Tissue Barriers 2014 2 e29528 10.4161/tisb.29528 25068098 PMC4106925 source
The Tumor Microenvironment section describes how the extracellular matrix and interstitial fluid pressure affect drug penetration, while acidity and hypoxia affect response to anticancer therapies. The Enhanced permeability and retention effect section explains that nanoparticles remain in tumors partly because of poor lymphatic drainage. Together, these passages support the broad claim, particularly for nanoparticle drug delivery. (LLM, conf=0.90)
- Supportedcites [3] Bartelink I.H. Jones E.F. Shahidi-Latham S.K. Lee P.R.E. Zheng Y. Vicini P. van’t Veer L. Wolf D. Iagaru A. Kroetz D.L. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle Clin. Pharmacol. Ther. 2019 106 148 163 10.1002/cpt.1211 30107040 PMC6617978 source
In “Studying tumor tissue penetration: Illustration and tools” (page unavailable), the paper says that tumor-microenvironment factors largely determine drug penetration and can limit drug distribution. In “Studying target binding at a cellular/molecular level: Illustration and tools” (page unavailable), it describes tumor macrophages and efflux transporters affecting drug accumulation; the penetration section also links immune-cell composition to immunotherapy efficacy. These passages support the broad claim about penetration, retention, and therapeutic response. (LLM, conf=0.88)
- Partly supportedcites [4] Goenka A. Khan F. Verma B. Sinha P. Dmello C.C. Jogalekar M.P. Gangadaran P. Ahn B.C. Tumor microenvironment signaling and therapeutics in cancer progression Cancer Commun. 2023 43 525 561 10.1002/cac2.12416 37005490 PMC10174093 sourceExperimental — accuracy not yet measured
In “TME-based cancer therapy” (page unavailable), the review says poor tumor vasculature protects the tumor core from therapeutics delivered through the bloodstream, supporting an effect on drug penetration. The same section describes microenvironmental factors altering treatment response and ECM-targeted agents localizing treatment in tumors, but it does not establish an effect on drug retention specifically. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Drug delivery to solid tumors is challenged by multiple physiological barriers arising from the tumor microenvironment, including dense extracellular matrix, cellular heterogeneity, hypoxic gradients, and elevated interstitial fluid pressure. These features hinder the uniform distribution and accumulation of therapeutics, reducing treatment efficacy.”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Partly supportedcites [1] Sriraman S.K. Aryasomayajula B. Torchilin V.P. Barriers to drug delivery in solid tumors Tissue Barriers 2014 2 e29528 10.4161/tisb.29528 25068098 PMC4106925 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [2] Khan S.U. Fatima K. Aisha S. Malik F. Unveiling the mechanisms and challenges of cancer drug resistance Cell Commun. Signal. 2024 22 109 10.1186/s12964-023-01302-1 38347575 PMC10860306 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [3] Bartelink I.H. Jones E.F. Shahidi-Latham S.K. Lee P.R.E. Zheng Y. Vicini P. van’t Veer L. Wolf D. Iagaru A. Kroetz D.L. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle Clin. Pharmacol. Ther. 2019 106 148 163 10.1002/cpt.1211 30107040 PMC6617978 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms.”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Not checked — no full text of the sourcecites [14] Friedrich J. Seidel C. Ebner R. Kunz-Schughart L.A. Spheroid-based drug screen: Considerations and practical approach Nat. Protoc. 2009 4 309 324 10.1038/nprot.2008.226 19214182 source
- Partly supportedcites [15] Vinci M. Gowan S. Boxall F. Patterson L. Zimmermann M. Court W. Lomas C. Mendiola M. Hardisson D. Eccles S.A. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation BMC Biol. 2012 10 29 10.1186/1741-7007-10-29 22439642 PMC3349530 sourceExperimental — accuracy not yet measured
The Background (page not available) says three-dimensional cultures better reflect tumor architecture and microenvironmental features. The Results (page not available) report that tumor cells were generally less drug-sensitive in three-dimensional culture, but offer reduced drug access and hypoxia-related effects as possible explanations rather than established resistance mechanisms. The Discussion (page not available) describes stromal-cell incorporation as a modification to spheroids, not a feature of spheroids generally. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [16] Hirschhaeuser F. Menne H. Dittfeld C. West J. Mueller-Klieser W. Kunz-Schughart L.A. Multicellular tumor spheroids: An underestimated tool is catching up again J. Biotechnol. 2010 148 3 15 10.1016/j.jbiotec.2010.01.012 20097238 source
- Supportedcites [17] Nath S. Devi G.R. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model Pharmacol. Ther. 2016 163 94 108 10.1016/j.pharmthera.2016.03.013 27063403 PMC4961208 source
Section 2.3 describes MCTS as reproducing tumor-cell characteristics and the layered structure and gradients of tumors. Section 5.5 reports that stromal interactions can alter drug sensitivity and describes resistance mechanisms in spheroids. The paper also notes that spheroids can be made with other cell types, so the claim does not imply every spheroid includes stroma. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk.”
- Also stated in: § 5. Spheroids as a More Physiologically Relevant TME Model · plain
“These gradients typically emerge when spheroids exceed ~500 μm in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Supportedcites [17] Nath S. Devi G.R. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model Pharmacol. Ther. 2016 163 94 108 10.1016/j.pharmthera.2016.03.013 27063403 PMC4961208 source
Section 2.3 describes large spheroids as having oxygen gradients and concentric cell layers: quiescent cells in the middle and highly proliferative cells at the outside. It also identifies oxygen deficiency as a cause of hypoxia. Page numbers are not provided in our copy. (LLM, conf=0.93)
- Supportedcites [184] Mehta G. Hsiao A.Y. Ingram M. Luker G.D. Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control Release 2012 164 192 204 10.1016/j.jconrel.2012.04.045 22613880 PMC3436947 source
The section “Spheroids as appropriate models for drug delivery” describes oxygen and proliferation gradients, with a quiescent layer inside an outer rim of proliferating cells. The section “Challenge 1: Forming and maintaining spheroids of uniform size” also describes a hypoxic core. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [185] Groebe K. Mueller-Klieser W. Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters Eur. Biophys. J. 1991 19 169 181 10.1007/BF00196343 2029873 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 5. Spheroids as a More Physiologically Relevant TME Model · plain
86 more claims · 55 with their cited sources checked
Create a free account to see all 162 claims and to verify the 7 references still open.
- It may state two separate claims as one. 63
- Probably not a substantial claim. 12
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“Confocal microscopy has been widely used to evaluate penetration profiles and is also capable of providing quantitative insights [294,295].”
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“This surrounding landscape—referred to as the tumor microenvironment (TME)—comprises a complex network of cellular, acellular, and immune components [5,20,21].”
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915 · cited 1×
“Importantly, ECM composition is not static; it undergoes continuous remodeling through enzymatic degradation, de novo synthesis, and reorganization, all of which are tightly regulated by the cellular constituents of the TME [79,81].”
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 2×
“This transition imparts enhanced migratory and invasive capacity, survival advantage under stress, and increased resistance to apoptotic stimuli [39,131–133].”
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 1×
“Importantly, this crosstalk is bidirectional: while tumor cells reshape the microenvironment to support growth and metastasis, stromal and ECM elements also exert selective pressures that drive tumor adaptation and evolution [24–26].”
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 1×
“In vivo, this dormancy is typically overcome through angiogenesis, during which newly formed blood vessels introduce shear forces that sustain endothelial sprouts and support the delivery of therapeutic agents [49,222].”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 2×
“Once within the TME, macrophages display remarkable phenotypic plasticity [67,68].”
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“There is now a growing appreciation for the need to target both tumor cells and their supportive microenvironment [22,23].”
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 1×
“Factors such as epithelial-to-mesenchymal transition (EMT), oncogene activation, metabolic reprogramming, and altered expression of growth factor receptors can modulate how tumor cells perceive and respond to fibroblast-derived cues [28,31,32].”
Research works printed but not linked: 1
- Shah S. Development of co-culture spheroid models of drug-resistant carcinomas for the in vitro testing of anti-tumor treatment strategies Doctor of Philosophy Dissertation MCPHS Boston, USA 2024
Cited by
Madan, A., Saini, R., Dhiman, N., Juan, S., & Satapathy, M. K. (2025) · Organoids · doi:10.3390/organoids4040023 · Cited by 24
“Organoids derived from CSC-enriched populations often demonstrate enhanced tumorigenicity, metastatic potential, and therapeutic resistance, making them ideal models for studying relapse, dormancy, and evolution under drug pressure [36].”
Cancer Metastasis: Therapeutic Challenges and Opportunities
Garemilla, S. S. S., Kadambala, M. C., Gampa, S. C., Chinthala, S., & Garimella, S. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03072-x · Cited by 15
“The bio-physical properties of the TME particularly its dense ECM and elevated interstitial fluid pressure limit uniform drug distribution and reduce therapeutic efficacy, often contributing to treatment failure and recurrence [98].”
Shukla, A. K., Shukla, S., Suryawanshi, S. P., Upadhyay, A. M., Ray, N., Thiruppathi, G., Dutta, S. D., & Mongre, R. K. (2025) · Current Oncology · doi:10.3390/curroncol32120653 · Cited by 10
“By integrating cellular, extracellular, and mechanical cues within a precisely engineered 3D matrix, these models overcome many limitations of conventional two-dimensional cultures, providing more physiologically relevant platforms for studying tumor biology [46,47].”
Mokhles, F., Moosavi, M. A., Gutiérrez-Uzquiza, Á., Velasco, G., Li, M., & Cordani, M. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218246 · Cited by 13
Stem Cell-Derived Organoids for Cancer Therapy: Precision Medicine and Drug Selection
Azim, M. M. N., Bhajan, S. K., Park, J. H., Abass, K. S., Rahman, A., Choi, M., Choi, J., Park, S., Kim, H. J., Akter, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072954 · Cited by 8
Metadata
- Authors
- Shah, S., & D’Souza, G. G. M.
- Affiliations
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Shah, Shrey
- ORCID
- Shah, Shrey
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-05-17
- Volume
- 14
- Issue
- 10
- Pages
- 732
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12110291
- OpenAlex
- W4410519085
- Cited by
- 83
- References
- 326
- Citations by year
- 2026: 72 · 2025: 11
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor spheroids, tumor microenvironment, solid tumors, drug delivery barriers, extracellular matrix, hypoxia, interstitial fluid pressure, tumor-stroma interactions, 3D tumor models, drug penetration, drug resistance, confocal microscopy, cytotoxicity
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Spheroids, Cellular, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.